Adrian Rabin
Lawyers
Associate in our IP & Commercial Transactions practice.
Experience
Recent Work
- Williams $325 million acquisition of Rimrock gathering and processing system
- Ascentage Pharma $126.4 million IPO
- GSK up to $1.15 billion acquisition of IDRx
- Uranium Energy $300 million at-the-market offering
- Revolution Medicines $750 million stock and pre-funded warrants offering
- ACELYRIN $150 million at-the-market offering
- Labcorp $2 billion senior notes offering
- Terns Pharmaceuticals $173 million stock and pre-funded warrants offering
- Recursion Pharmaceuticals $230 million follow-on offering
- Sealed Air $400 million senior notes offering and concurrent tender offer
- Applied Materials $700 million senior notes offering
- Medtronic €3 billion notes offering
- RxSight $115 million follow-on offering
- Oculis Holding $100 million at-the-market offering
- SS&C Technologies $750 million senior notes offering
- Korro Bio $70 million private placement
Education
J.D., Cornell Law School
- Online Editor, Cornell International Law Journal
B.A., Biology, Emory University
Qualifications and admissions
- State of New York
- U.S. District Court, S.D. New York